Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD Patients

Clinical trial NCT04168216 · COMPLETED

Trial details

NCT number: NCT04168216
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2020-11-30
Primary completion: 2022-06-22
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.